Wolverine Trading’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,500
| Closed | -$438K | – | 5319 |
|
|
2025
Q1 | $438K | Sell |
62,500
-9,700
| -13% | -$80.2K | ﹤0.01% | 3120 |
|
|
2024
Q4 | $573K | Sell |
72,200
-64,300
| -47% | -$620K | ﹤0.01% | 3245 |
|
|
2024
Q3 | $1.82M | Buy |
136,500
+2,000
| +1% | +$25.8K | ﹤0.01% | 1775 |
|
|
2024
Q2 | $1.7M | Buy |
134,500
+80,700
| +150% | +$812K | ﹤0.01% | 1724 |
|
|
2024
Q1 | $257K | Buy |
+53,800
| New | +$250K | ﹤0.01% | 3526 |
|
|
2023
Q4 | – | Sell |
-117,100
| Closed | -$848K | – | 4979 |
|
|
2023
Q3 | $848K | Buy |
+117,100
| New | +$936K | ﹤0.01% | 2252 |
|
|
2023
Q2 | – | Sell |
-113,100
| Closed | -$745K | – | 4711 |
|
|
2023
Q1 | $745K | Buy |
113,100
+18,600
| +20% | +$171K | ﹤0.01% | 2163 |
|
|
2022
Q4 | $971K | Buy |
+94,500
| New | +$1.67M | ﹤0.01% | 1864 |
|
|
2022
Q3 | – | Sell |
-104,900
| Closed | -$5.44M | – | 5102 |
|
|
2022
Q2 | $5.44M | Sell |
104,900
-20,600
| -16% | -$1.07M | 0.01% | 782 |
|
|
2022
Q1 | $9.38M | Sell |
125,500
-53,300
| -30% | -$4.75M | 0.01% | 730 |
|
|
2021
Q4 | $27.7M | Buy |
178,800
+7,900
| +5% | +$1.36M | 0.03% | 377 |
|
|
2021
Q3 | $34.8M | Buy |
170,900
+31,200
| +22% | +$6.88M | 0.04% | 332 |
|
|
2021
Q2 | $29.2M | Buy |
139,700
+41,800
| +43% | +$7.66M | 0.05% | 299 |
|
|
2021
Q1 | $17M | Sell |
97,900
-25,100
| -20% | -$5M | 0.03% | 461 |
|
|
2020
Q4 | $14.6M | Buy |
123,000
+29,400
| +31% | +$3.12M | 0.02% | 495 |
|
|
2020
Q3 | $10.1M | Buy |
93,600
+8,100
| +9% | +$987K | 0.02% | 530 |
|
|
2020
Q2 | $7.15M | Buy |
85,500
+27,700
| +48% | +$1.06M | 0.02% | 620 |
|
|
2020
Q1 | $827K | Buy |
+57,800
| New | +$489K | ﹤0.01% | 2111 |
|
|
2019
Q1 | – | Sell |
-2,630
| Closed | -$97K | – | 5054 |
|
|
2018
Q4 | $97K | Buy |
2,630
+1,395
| +113% | +$54.1K | ﹤0.01% | 3995 |
|
|
2018
Q3 | $46K | Sell |
1,235
-890
| -42% | -$25.1K | ﹤0.01% | 4720 |
|
|
2018
Q2 | $89K | Hold |
2,125
| – | – | ﹤0.01% | 4763 |
|
|
2018
Q1 | $89K | Buy |
2,125
+1,620
| +321% | +$65.1K | ﹤0.01% | 4763 |
|
|
2017
Q4 | $13K | Sell |
505
-1,285
| -72% | -$31.4K | ﹤0.01% | 4698 |
|
|
2017
Q3 | $41K | Sell |
1,790
-920
| -34% | -$20.6K | ﹤0.01% | 4259 |
|
|
2017
Q2 | $62K | Sell |
2,710
-40
| -1% | -$785 | ﹤0.01% | 4012 |
|
|
2017
Q1 | $69K | Sell |
2,750
-440
| -14% | -$12.1K | ﹤0.01% | 3926 |
|
|
2016
Q4 | $80K | Sell |
3,190
-8,485
| -73% | -$247K | ﹤0.01% | 4114 |
|
|
2016
Q3 | $481K | Buy |
11,675
+3,950
| +51% | +$510K | ﹤0.01% | 2613 |
|
|
2016
Q2 | $1.11M | Buy |
+7,725
| New | +$885K | 0.01% | 1514 |
|
Other funds holding NVAX
SCM
S
Wolverine Trading's NVAX Position: Q2 2025 in Review
Wolverine Trading sold out of Novavax (NVAX) in Q2 2025, closing a stake of 24,208 shares — an estimated $169K sold.
Wolverine Trading first reported a position in NVAX in Q2 2016 and held it in 24 quarters. The position peaked at $8.63M in Q2 2021. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.
- Wolverine Trading reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 24,208 Novavax shares in Q2 2025, an estimated $169K.
- Wolverine Trading first reported a position in Novavax in Q2 2016 and held it in 24 quarters.
- Wolverine Trading's Novavax position peaked at $8.63M in Q2 2021.
- 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.